首页 > 最新文献

JAMA ophthalmology最新文献

英文 中文
Bilateral Retinal Nerve Fiber Layer Thickening in a Middle-Aged Woman. 中年妇女双侧视网膜神经纤维层增厚。
IF 7.8 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-02-01 DOI: 10.1001/jamaophthalmol.2024.5457
Ivy Zhu, Amani A Fawzi
{"title":"Bilateral Retinal Nerve Fiber Layer Thickening in a Middle-Aged Woman.","authors":"Ivy Zhu, Amani A Fawzi","doi":"10.1001/jamaophthalmol.2024.5457","DOIUrl":"10.1001/jamaophthalmol.2024.5457","url":null,"abstract":"","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":" ","pages":"178-179"},"PeriodicalIF":7.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142854089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-Eye Gene Therapy for Leber Hereditary Optic Neuropathy. Leber遗传性视神经病变的单眼基因治疗。
IF 7.8 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-02-01 DOI: 10.1001/jamaophthalmol.2024.5618
Hendrik P N Scholl, Bence György
{"title":"Single-Eye Gene Therapy for Leber Hereditary Optic Neuropathy.","authors":"Hendrik P N Scholl, Bence György","doi":"10.1001/jamaophthalmol.2024.5618","DOIUrl":"10.1001/jamaophthalmol.2024.5618","url":null,"abstract":"","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":" ","pages":"108-109"},"PeriodicalIF":7.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142854121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Geographic Distribution of US Ophthalmic Surgical Subspecialists. 美国眼科专科医生的地理分布。
IF 7.8 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-02-01 DOI: 10.1001/jamaophthalmol.2024.5605
Aishah Ahmed, Muhammad Ali, Chen Dun, Cindy X Cai, Martin A Makary, Fasika A Woreta

Importance: While urban counties maintain higher densities of ophthalmologists than rural counties, the geographic distribution of ophthalmic surgical subspecialists has not yet been elucidated. A potential workforce discrepancy may impact the burden of care faced by rural surgeons.

Objective: To assess the geographic distribution of the ophthalmic subspecialist surgeon workforce and evaluate factors associated with practicing in rural areas.

Design, setting, and participants: This cross-sectional population-based study of Medicare patients and surgeons performing subspecialized procedures took place from 2012 through 2022. Medicare Fee-for-Service claims were analyzed in 2023 for patients 65 years or older who underwent subspecialized ophthalmic procedures between 2012 and 2022 using Current Procedural Terminology codes (n = 1 619 043). Surgeons were defined as a subspecialist based on Current Procedural Terminology codes, indicating performance of at least 1 subspecialty procedure from the following subspecialties: cornea, glaucoma, oculoplastic, retina, or strabismus (n = 13 526).

Main outcomes and measures: The primary outcome was the population density of practice for subspecialist surgeons and residence for patients (rural or urban). The secondary outcomes were the characteristics associated with rural practice.

Results: Among 13 526 ophthalmic surgical subspecialists, 9823 were male (72.6%), 3235 were female (26.8%), and 4484 (33.2%) practiced in the South. There were 2540 cornea subspecialists (18.5%), 3676 glaucoma subspecialists (26.8%), 1951 oculoplastic subspecialists (14.2%), 4123 retina subspecialists (30.0%), and 1236 strabismus subspecialists (9.0%). Across subspecialties, a higher proportion of patients (17.4%; 95% CI, 16.9%-17.9%) resided in rural areas relative to surgeons (5.6%; 95% CI, 5.3%-5.9%) with differences ranging from 6.2% to 14.8% across subspecialities. Female surgeons (adjusted odds ratio [aOR], 0.63; 95% CI, 0.51-0.79; P < .001), surgeons in the Northeast (aOR, 0.62; 95% CI, 0.48-0.78; P < .001), surgeons in the West (aOR, 0.63; 95% CI, 0.50-0.79; P < .001), and recent graduates relative to those who graduated 11 to 20 years ago (aOR, 1.66; 95% CI, 1.25-2.21; P < .001), 21 to 30 years ago (aOR, 1.83; 95% CI, 1.38-2.42; P < .001), or 31 years ago or longer (aOR, 1.43; 95% CI, 1.08-1.90; P = .013), were less likely to practice rurally.

Conclusions and relevance: This cross-sectional study between 2012 and 2022 identified higher proportions of rural patients compared with rural surgeons. Percentages of rural surgeons declined over time, with female surgeons and recent medical school graduates less likely to practice rurally. This suggests a disparity in the number of rural subspecialist surgeons available to serve rural patients.

重要性:虽然城市县的眼科医生密度高于农村县,但眼科外科专科医生的地理分布尚未明确。潜在的劳动力差异可能会影响农村外科医生面临的护理负担。目的:评估眼科专科外科医生队伍的地理分布,并评估与农村地区执业相关的因素。设计、环境和参与者:这项以人口为基础的横断面研究于2012年至2022年进行,研究对象为医疗保险患者和进行亚专科手术的外科医生。使用现行程序术语代码(n = 1 619 043)分析了2012年至2022年期间接受亚专科眼科手术的65岁及以上患者在2023年的医疗保险服务收费索赔。根据现行程序术语规范,外科医生被定义为亚专科医生,表明至少执行了以下亚专科的1个亚专科手术:角膜、青光眼、眼成形术、视网膜或斜视(n = 13 526)。主要结局和措施:主要结局是亚专科外科医生的执业人口密度和患者的居住地(农村或城市)。次要结局是与农村实践相关的特征。结果:13 526名眼科专科医生中,男性9823人(72.6%),女性3235人(26.8%),南方地区4484人(33.2%)。角膜亚专科2540人(18.5%),青光眼亚专科3676人(26.8%),眼整形亚专科1951人(14.2%),视网膜亚专科4123人(30.0%),斜视亚专科1236人(9.0%)。在亚专科中,更高比例的患者(17.4%;95% CI, 16.9%-17.9%)相对于外科医生居住在农村地区(5.6%;95% CI, 5.3%-5.9%),不同亚专科的差异在6.2% - 14.8%之间。女外科医生(校正优势比[aOR], 0.63;95% ci, 0.51-0.79;结论和相关性:这项2012年至2022年的横断面研究发现,与农村外科医生相比,农村患者的比例更高。随着时间的推移,农村外科医生的比例下降,女外科医生和最近的医学院毕业生不太可能在农村执业。这表明可为农村病人提供服务的农村专科外科医生的数量存在差异。
{"title":"Geographic Distribution of US Ophthalmic Surgical Subspecialists.","authors":"Aishah Ahmed, Muhammad Ali, Chen Dun, Cindy X Cai, Martin A Makary, Fasika A Woreta","doi":"10.1001/jamaophthalmol.2024.5605","DOIUrl":"10.1001/jamaophthalmol.2024.5605","url":null,"abstract":"<p><strong>Importance: </strong>While urban counties maintain higher densities of ophthalmologists than rural counties, the geographic distribution of ophthalmic surgical subspecialists has not yet been elucidated. A potential workforce discrepancy may impact the burden of care faced by rural surgeons.</p><p><strong>Objective: </strong>To assess the geographic distribution of the ophthalmic subspecialist surgeon workforce and evaluate factors associated with practicing in rural areas.</p><p><strong>Design, setting, and participants: </strong>This cross-sectional population-based study of Medicare patients and surgeons performing subspecialized procedures took place from 2012 through 2022. Medicare Fee-for-Service claims were analyzed in 2023 for patients 65 years or older who underwent subspecialized ophthalmic procedures between 2012 and 2022 using Current Procedural Terminology codes (n = 1 619 043). Surgeons were defined as a subspecialist based on Current Procedural Terminology codes, indicating performance of at least 1 subspecialty procedure from the following subspecialties: cornea, glaucoma, oculoplastic, retina, or strabismus (n = 13 526).</p><p><strong>Main outcomes and measures: </strong>The primary outcome was the population density of practice for subspecialist surgeons and residence for patients (rural or urban). The secondary outcomes were the characteristics associated with rural practice.</p><p><strong>Results: </strong>Among 13 526 ophthalmic surgical subspecialists, 9823 were male (72.6%), 3235 were female (26.8%), and 4484 (33.2%) practiced in the South. There were 2540 cornea subspecialists (18.5%), 3676 glaucoma subspecialists (26.8%), 1951 oculoplastic subspecialists (14.2%), 4123 retina subspecialists (30.0%), and 1236 strabismus subspecialists (9.0%). Across subspecialties, a higher proportion of patients (17.4%; 95% CI, 16.9%-17.9%) resided in rural areas relative to surgeons (5.6%; 95% CI, 5.3%-5.9%) with differences ranging from 6.2% to 14.8% across subspecialities. Female surgeons (adjusted odds ratio [aOR], 0.63; 95% CI, 0.51-0.79; P < .001), surgeons in the Northeast (aOR, 0.62; 95% CI, 0.48-0.78; P < .001), surgeons in the West (aOR, 0.63; 95% CI, 0.50-0.79; P < .001), and recent graduates relative to those who graduated 11 to 20 years ago (aOR, 1.66; 95% CI, 1.25-2.21; P < .001), 21 to 30 years ago (aOR, 1.83; 95% CI, 1.38-2.42; P < .001), or 31 years ago or longer (aOR, 1.43; 95% CI, 1.08-1.90; P = .013), were less likely to practice rurally.</p><p><strong>Conclusions and relevance: </strong>This cross-sectional study between 2012 and 2022 identified higher proportions of rural patients compared with rural surgeons. Percentages of rural surgeons declined over time, with female surgeons and recent medical school graduates less likely to practice rurally. This suggests a disparity in the number of rural subspecialist surgeons available to serve rural patients.</p>","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":" ","pages":"117-124"},"PeriodicalIF":7.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11843353/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142914759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addressing Representation in Ophthalmology Training. 解决眼科培训中的代表性问题。
IF 7.8 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-02-01 DOI: 10.1001/jamaophthalmol.2024.6086
Khalid El-Jack, Dolly Ann Padovani-Claudio, Basil K Williams
{"title":"Addressing Representation in Ophthalmology Training.","authors":"Khalid El-Jack, Dolly Ann Padovani-Claudio, Basil K Williams","doi":"10.1001/jamaophthalmol.2024.6086","DOIUrl":"10.1001/jamaophthalmol.2024.6086","url":null,"abstract":"","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":" ","pages":"152-154"},"PeriodicalIF":7.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143005412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beaded Bubbles in the Eye After Vitrectomy and Gas Fill.
IF 7.8 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-02-01 Epub Date: 2025-02-20 DOI: 10.1001/jamaophthalmol.2024.5707
Yanyan Zhang, Yan Gong, Quanyong Yi
{"title":"Beaded Bubbles in the Eye After Vitrectomy and Gas Fill.","authors":"Yanyan Zhang, Yan Gong, Quanyong Yi","doi":"10.1001/jamaophthalmol.2024.5707","DOIUrl":"https://doi.org/10.1001/jamaophthalmol.2024.5707","url":null,"abstract":"","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":"143 2","pages":"e245707"},"PeriodicalIF":7.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143458122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fovea-Involved Outer Retinal Abnormality Induced by a Novel RET Inhibitor. 一种新型RET抑制剂诱导的涉及中央凹的外视网膜异常。
IF 7.8 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-02-01 DOI: 10.1001/jamaophthalmol.2024.5236
Langxuan Yuan, Shan Gao, Shimin Tan, Qianyan Kang, Jianqin Lei
{"title":"Fovea-Involved Outer Retinal Abnormality Induced by a Novel RET Inhibitor.","authors":"Langxuan Yuan, Shan Gao, Shimin Tan, Qianyan Kang, Jianqin Lei","doi":"10.1001/jamaophthalmol.2024.5236","DOIUrl":"10.1001/jamaophthalmol.2024.5236","url":null,"abstract":"","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":" ","pages":"186-188"},"PeriodicalIF":7.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142812563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
JAMA Ophthalmology.
IF 7.8 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-02-01 DOI: 10.1001/jamaophthalmol.2024.4158
{"title":"JAMA Ophthalmology.","authors":"","doi":"10.1001/jamaophthalmol.2024.4158","DOIUrl":"https://doi.org/10.1001/jamaophthalmol.2024.4158","url":null,"abstract":"","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":"143 2","pages":"90"},"PeriodicalIF":7.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143457604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pediatric Patient Referred for an Optic Nerve Mass. 小儿患者因视神经肿块转诊。
IF 7.8 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-02-01 DOI: 10.1001/jamaophthalmol.2024.5597
Justin J Grassmeyer, Alison H Skalet, Benjamin K Young
{"title":"Pediatric Patient Referred for an Optic Nerve Mass.","authors":"Justin J Grassmeyer, Alison H Skalet, Benjamin K Young","doi":"10.1001/jamaophthalmol.2024.5597","DOIUrl":"10.1001/jamaophthalmol.2024.5597","url":null,"abstract":"","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":" ","pages":"182-183"},"PeriodicalIF":7.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142914762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quantifying Patient Preferences and Expectations About Diabetic Retinopathy Monitoring. 量化患者对糖尿病视网膜病变监测的偏好和期望。
IF 7.8 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-02-01 DOI: 10.1001/jamaophthalmol.2024.5365
Juan Marcos Gonzalez Sepulveda, Jui-Chen Yang, Alicja Mastylak, Elaine M Wells-Gray, Landon Grace, Stephen Fransen
<p><strong>Importance: </strong>Diabetic retinopathy (DR) is the leading cause of blindness among adults in the US. The US Centers for Disease Control and Prevention recommends annual DR monitoring for all individuals with diabetes, yet monitoring rates remain below 70%.</p><p><strong>Objective: </strong>To evaluate how patient preferences and expectations about DR monitoring are associated with expected monitoring adherence behaviors.</p><p><strong>Design, setting, and participants: </strong>In this survey study, a web-enabled survey instrument was developed and implemented with a discrete-choice experiment to characterize patient preferences for outcomes of DR monitoring and graded-pair questions to quantify patients' expectations about the impact of DR monitoring on blindness risk. The survey was conducted through ResearchMatch, a US National Institutes of Health-developed online platform, among adults with self-reported, physician-diagnosed diabetes. Recruitment occurred between September 15, 2023, and October, 17, 2023, and data analysis occurred between October 2023 and December 2023. Results from the 2 tasks were combined to derive patients' expected monitoring behavior following a recently proposed treatment adherence framework. The survey instrument was pretested in cognitive interviews and validated for the purposes of this study.</p><p><strong>Exposure: </strong>Survey-based discrete-choice experiment and graded-pair questions.</p><p><strong>Main outcomes and measures: </strong>Participants' relative preferences for DR-related blindness risk reductions, monitoring time, and out-of-pocket monitoring costs were quantified, as well as the degree to which participants expected adherence to monitoring to affect the risk of blindness. By combining how much participants valued specific reductions in blindness risk (relative to monitoring costs) and their expected risk reduction through monitoring, the rate at which patients would maximize the benefit of monitoring appointments was assessed.</p><p><strong>Results: </strong>The survey was completed satisfactorily by 304 respondents of 542 individuals invited to participate. Mean (SD) respondent age was 40.5 (11.2) years, and 169 respondents (56.1%) were female. Reductions in blindness risk were valuable to participants. Participants required a 3.87 (95% CI, 1.91-5.88) percentage-point reduction in 5-year blindness risk to be fully adherent to an annual 53-minute monitoring visit with a $26 co-payment, but respondents expected DR monitoring to reduce the 5-year blindness risk by 0.71 (95% CI, 0.21-1.28) percentage points.</p><p><strong>Conclusions and relevance: </strong>In this online survey study among adults with diabetes, measurement of patient preferences and expectations about DR monitoring with properly validated instruments offered an opportunity to assess patient health behaviors. The association between preferences and monitoring expectations was generally consistent with monitoring no
重要性:糖尿病视网膜病变(DR)是美国成年人失明的主要原因。美国疾病控制和预防中心建议对所有糖尿病患者每年进行DR监测,但监测率仍低于70%。目的:评估患者对DR监测的偏好和期望与预期监测依从性行为的关系。设计、设置和参与者:在这项调查研究中,开发了一种基于网络的调查工具,并采用离散选择实验来表征患者对DR监测结果的偏好,并采用分级配对问题来量化患者对DR监测对失明风险影响的期望。这项调查是通过ResearchMatch进行的,ResearchMatch是美国国立卫生研究院开发的在线平台,调查对象是自我报告、医生诊断为糖尿病的成年人。招聘时间为2023年9月15日至2023年10月17日,数据分析时间为2023年10月至2023年12月。根据最近提出的治疗依从性框架,将两项任务的结果结合起来得出患者预期的监测行为。调查工具在认知访谈中进行了预测试,并为本研究的目的进行了验证。暴露:基于调查的离散选择实验和分级配对问题。主要结果和测量:量化了参与者对dr相关失明风险降低、监测时间和自付监测费用的相对偏好,以及参与者期望遵守监测影响失明风险的程度。通过结合参与者对特定失明风险降低的重视程度(相对于监测成本)和他们通过监测预期的风险降低,评估了患者从监测预约中获益最大化的比率。结果:本次调查共邀请542人参与,304人圆满完成。受访者平均年龄(SD)为40.5(11.2)岁,女性169人(56.1%)。失明风险的降低对参与者来说是有价值的。参与者要求完全遵守每年53分钟的监测访问和26美元的共付费用,将5年失明风险降低3.87 (95% CI, 1.91-5.88)个百分点,但受访者期望DR监测将5年失明风险降低0.71 (95% CI, 0.21-1.28)个百分点。结论和相关性:在这项针对成人糖尿病患者的在线调查研究中,通过测量患者对DR监测的偏好和期望,为评估患者的健康行为提供了机会。偏好和监测期望之间的关联与糖尿病成人患者的不依从性监测大体一致,并提供了可能有助于解决不一致的DR监测的见解。
{"title":"Quantifying Patient Preferences and Expectations About Diabetic Retinopathy Monitoring.","authors":"Juan Marcos Gonzalez Sepulveda, Jui-Chen Yang, Alicja Mastylak, Elaine M Wells-Gray, Landon Grace, Stephen Fransen","doi":"10.1001/jamaophthalmol.2024.5365","DOIUrl":"10.1001/jamaophthalmol.2024.5365","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Importance: &lt;/strong&gt;Diabetic retinopathy (DR) is the leading cause of blindness among adults in the US. The US Centers for Disease Control and Prevention recommends annual DR monitoring for all individuals with diabetes, yet monitoring rates remain below 70%.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To evaluate how patient preferences and expectations about DR monitoring are associated with expected monitoring adherence behaviors.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design, setting, and participants: &lt;/strong&gt;In this survey study, a web-enabled survey instrument was developed and implemented with a discrete-choice experiment to characterize patient preferences for outcomes of DR monitoring and graded-pair questions to quantify patients' expectations about the impact of DR monitoring on blindness risk. The survey was conducted through ResearchMatch, a US National Institutes of Health-developed online platform, among adults with self-reported, physician-diagnosed diabetes. Recruitment occurred between September 15, 2023, and October, 17, 2023, and data analysis occurred between October 2023 and December 2023. Results from the 2 tasks were combined to derive patients' expected monitoring behavior following a recently proposed treatment adherence framework. The survey instrument was pretested in cognitive interviews and validated for the purposes of this study.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Exposure: &lt;/strong&gt;Survey-based discrete-choice experiment and graded-pair questions.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main outcomes and measures: &lt;/strong&gt;Participants' relative preferences for DR-related blindness risk reductions, monitoring time, and out-of-pocket monitoring costs were quantified, as well as the degree to which participants expected adherence to monitoring to affect the risk of blindness. By combining how much participants valued specific reductions in blindness risk (relative to monitoring costs) and their expected risk reduction through monitoring, the rate at which patients would maximize the benefit of monitoring appointments was assessed.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The survey was completed satisfactorily by 304 respondents of 542 individuals invited to participate. Mean (SD) respondent age was 40.5 (11.2) years, and 169 respondents (56.1%) were female. Reductions in blindness risk were valuable to participants. Participants required a 3.87 (95% CI, 1.91-5.88) percentage-point reduction in 5-year blindness risk to be fully adherent to an annual 53-minute monitoring visit with a $26 co-payment, but respondents expected DR monitoring to reduce the 5-year blindness risk by 0.71 (95% CI, 0.21-1.28) percentage points.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions and relevance: &lt;/strong&gt;In this online survey study among adults with diabetes, measurement of patient preferences and expectations about DR monitoring with properly validated instruments offered an opportunity to assess patient health behaviors. The association between preferences and monitoring expectations was generally consistent with monitoring no","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":" ","pages":"91-98"},"PeriodicalIF":7.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11842207/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142854120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corneal Recovery After Neurotization for Neurotrophic Keratopathy.
IF 7.8 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-02-01 Epub Date: 2025-02-20 DOI: 10.1001/jamaophthalmol.2024.5706
Yuan Chang, Tao Zhang, Xiaowei Liu
{"title":"Corneal Recovery After Neurotization for Neurotrophic Keratopathy.","authors":"Yuan Chang, Tao Zhang, Xiaowei Liu","doi":"10.1001/jamaophthalmol.2024.5706","DOIUrl":"https://doi.org/10.1001/jamaophthalmol.2024.5706","url":null,"abstract":"","PeriodicalId":14518,"journal":{"name":"JAMA ophthalmology","volume":"143 2","pages":"e245706"},"PeriodicalIF":7.8,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143457527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JAMA ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1